PMID: 8944589Nov 1, 1996Paper

Changing patterns of investigation and treatment of cardiac failure in hospital

Heart
G S HillisK P Jennings

Abstract

To assess the investigation and treatment of cardiac failure in 1995 and to compare this with management in 1992. Retrospective consecutive case study. University teaching hospital. All patients (n = 265) discharged from Aberdeen Royal Infirmary in the first quarter (January 1-31 March) of 1995 with a diagnosis of congestive cardiac failure, left ventricular failure, or heart failure (unspecified). These correspond to the International Classification of Diseases 9th revision codings of 428.0, 428.1, and 428.9 respectively. Sociodemographic and clinical data were extracted from the case notes of the above subjects and compared with similar data from the final six months of 1992. The use of echocardiography in confirming the diagnosis and delineating the aetiology of heart failure and the use of angiotensin-converting enzyme (ACE) inhibitors in the treatment of patients diagnosed as having heart failure and without contraindications to these agents. The number of patients discharged in 1995 with a diagnosis including cardiac failure had increased by 55.7% since 1992. The use of echocardiography had also risen from 36.6% to 72% (P < 0.0001) with an associated increase in the proportion of patients discharged on treatment with an A...Continue Reading

References

Sep 3, 1992·The New England Journal of Medicine·J N Cohn
Mar 11, 1995·BMJ : British Medical Journal·C M FrancisJ J McMurray
Apr 15, 1995·BMJ : British Medical Journal·A L Clark, A J Coats
Sep 1, 1994·British Heart Journal·J G Cleland, P A Poole-Wilson
Jun 1, 1994·British Heart Journal·K W ClarkeJ R Hampton
Sep 1, 1993·European Heart Journal·J McMurrayH J Dargie
Feb 1, 1996·QJM : Monthly Journal of the Association of Physicians·G S HillisK P Jennings

❮ Previous
Next ❯

Citations

Dec 29, 2000·Journal of the American College of Cardiology·A KhandJ G Cleland
Jul 30, 2002·European Journal of Internal Medicine·P S. WongC Davidson
Dec 15, 2005·Heart, Lung & Circulation·John H WlodarczykCate McCosker
Apr 5, 2002·Journal of the American Academy of Nurse Practitioners·S L Schafer
Nov 4, 2000·BMJ : British Medical Journal·J G ClelandJ L Caplin
Aug 10, 2000·European Journal of Heart Failure·J G ClelandA Boddy
Jan 29, 2002·European Journal of Heart Failure·Christopher T C LienMarion E T McMurdo
Nov 30, 2002·Lancet·J G F ClelandUNKNOWN Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology
Sep 15, 1998·Lancet·J G ClelandP A Poole-Wilson
Mar 25, 1999·The American Journal of Cardiology·J G Cleland, A Clark

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.